Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-01-09 @ 3:32 PM
Study NCT ID:
NCT03359005
Status:
UNKNOWN
Last Update Posted:
2022-11-01
First Post:
2017-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan and Temozolomide for Ewing Sarcoma
Sponsor:
Peking University People's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2017-11-26
First Submit QC Date:
None
Study First Post Date:
2017-12-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-31
Last Update Post Date:
2022-11-01
Last Update Post Date Type:
ACTUAL